Company Filing History:
Years Active: 2006-2007
Title: Anton Shalimov: Innovator in Pharmaceutical Processes
Introduction
Anton Shalimov is a notable inventor based in Haifa, Israel, recognized for his contributions to pharmaceutical chemistry. With two patents to his name, his work primarily focuses on processes that enhance the preparation of important medications.
Latest Patents
Anton has introduced innovative methods in the field of pharmacology, notably with his recent patents. The first, titled "Process for the preparation of dexmethylphenidate hydrochloride," outlines an efficient process for synthesizing dexmethylphenidate hydrochloride, achieving high optical purity. This invention also presents a new intermediate in the preparation process, specifically the salt of (R,R)-N-Boc-ritalinic acid with (S)-1-phenylethylamine.
The second patent, "Process for the preparation of threo-methylphenidate hydrochloride," further expands on his expertise in this area, providing a detailed procedural framework for the synthesis of threo-methylphenidate hydrochloride. Both patents reflect Anton's commitment to improving pharmaceutical manufacturing processes.
Career Highlights
Anton is associated with Isp Investments Inc., a company where he leverages his skills and knowledge in pharmaceutical innovation. His dedication to research and development positions him as a key player in his field, contributing significantly to advancements in medication preparation.
Collaborations
Throughout his career, Anton has collaborated with talented professionals such as Arie L Gutman and Igor Zaltsman. These partnerships exemplify a collaborative spirit in the pursuit of innovation and the enhancement of pharmaceutical technologies.
Conclusion
In summary, Anton Shalimov stands out as an influential inventor in the pharmaceutical sector. His innovative patents contribute valuable processes to the preparation of essential medications, thereby underscoring the importance of his work in advancing healthcare solutions.